Concepedia

Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy

Maria Gabelli, Macarena Oporto Espuelas, Saskia Burridge, Jan Chu, Susan Farish, Emma Hedges, Kirsty Ware, Lindsey Williams, Lindsey Young, Rajesh Alajangi,

Blood Advances · 2023 · 26 citations · 13 references

DOIFull text

Open access

Concepts

References

13

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner et al. · New England Journal of Medicine · 2018 · 5.6K citations · Full text

, , +17

CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

Cameron J. Turtle, Laïla‐Aïcha Hanafi, Carolina Berger et al. · Journal of Clinical Investigation · 2016 · 2.1K citations · Full text

, , +17

Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma

Marcelo C. Pasquini, Zhen‐Huan Hu, Kevin J. Curran et al. · Blood Advances · 2020 · 434 citations · Full text

, , +17

Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia

Karen Thudium Mueller, Shannon L. Maude, David L. Porter et al. · Blood · 2017 · 359 citations · Full text

, , +13

Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial

Theodore W. Laetsch, Shannon L. Maude, Susana Rives et al. · Journal of Clinical Oncology · 2022 · 357 citations · Full text

, , +17